Cargando…

FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress

BACKGROUND: Chronic low-grade inflammation and oxidative stress play important roles in the development of obesity-induced cardiac hypertrophy. Here, we investigated the role of Fibronectin type III domain containing 5 (FNDC5) in cardiac inflammation and oxidative stress in obesity-induced cardiac h...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Zhi, Fan, Wen-Yong, Zhou, Bing, Ye, Chao, Tong, Ying, Zhou, Ye-Bo, Xiong, Xiao-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444535/
https://www.ncbi.nlm.nih.gov/pubmed/30940158
http://dx.doi.org/10.1186/s12967-019-1857-8
_version_ 1783408045328433152
author Geng, Zhi
Fan, Wen-Yong
Zhou, Bing
Ye, Chao
Tong, Ying
Zhou, Ye-Bo
Xiong, Xiao-Qing
author_facet Geng, Zhi
Fan, Wen-Yong
Zhou, Bing
Ye, Chao
Tong, Ying
Zhou, Ye-Bo
Xiong, Xiao-Qing
author_sort Geng, Zhi
collection PubMed
description BACKGROUND: Chronic low-grade inflammation and oxidative stress play important roles in the development of obesity-induced cardiac hypertrophy. Here, we investigated the role of Fibronectin type III domain containing 5 (FNDC5) in cardiac inflammation and oxidative stress in obesity-induced cardiac hypertrophy. METHODS: Male wild-type and FNDC5(−/−) mice were fed normal chow or high fat diet (HFD) for 20 weeks to induce obesity, and primary cardiomyocytes and H9c2 cells treated with palmitate (PA) were used as in vitro model. The therapeutic effects of lentiviral vector-mediated FNDC5 overexpression were also examined in HFD-induced cardiac hypertrophy. RESULTS: High fat diet manifested significant increases in body weight and cardiac hypertrophy marker genes expression, while FNDC5 deficiency aggravated cardiac hypertrophy evidenced by increased Nppa, Nppb and Myh7 mRNA level and cardiomyocytes area, in association with enhanced cardiac inflammatory cytokines expression, oxidative stress level and JAK2/STAT3 activation in HFD-fed mice. FNDC5 deficiency in primary cardiomyocytes or FNDC5 knockdown in H9c2 cells enhanced PA-induced inflammatory responses and NOX4 expression. Exogenous FNDC5 pretreatment attenuated PA-induced cardiomyocytes hypertrophy, inflammatory cytokines up-regulation and oxidative stress in primary cardiomyocytes and H9c2 cells. FNDC5 overexpression attenuated cardiac hypertrophy as well as cardiac inflammation and oxidative stress in HFD-fed mice. CONCLUSIONS: FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3 associated-cardiac inflammation and oxidative stress. The cardio-protective role of FNDC5 shed light on future therapeutic interventions in obesity and related cardiovascular complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1857-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6444535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64445352019-04-11 FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress Geng, Zhi Fan, Wen-Yong Zhou, Bing Ye, Chao Tong, Ying Zhou, Ye-Bo Xiong, Xiao-Qing J Transl Med Research BACKGROUND: Chronic low-grade inflammation and oxidative stress play important roles in the development of obesity-induced cardiac hypertrophy. Here, we investigated the role of Fibronectin type III domain containing 5 (FNDC5) in cardiac inflammation and oxidative stress in obesity-induced cardiac hypertrophy. METHODS: Male wild-type and FNDC5(−/−) mice were fed normal chow or high fat diet (HFD) for 20 weeks to induce obesity, and primary cardiomyocytes and H9c2 cells treated with palmitate (PA) were used as in vitro model. The therapeutic effects of lentiviral vector-mediated FNDC5 overexpression were also examined in HFD-induced cardiac hypertrophy. RESULTS: High fat diet manifested significant increases in body weight and cardiac hypertrophy marker genes expression, while FNDC5 deficiency aggravated cardiac hypertrophy evidenced by increased Nppa, Nppb and Myh7 mRNA level and cardiomyocytes area, in association with enhanced cardiac inflammatory cytokines expression, oxidative stress level and JAK2/STAT3 activation in HFD-fed mice. FNDC5 deficiency in primary cardiomyocytes or FNDC5 knockdown in H9c2 cells enhanced PA-induced inflammatory responses and NOX4 expression. Exogenous FNDC5 pretreatment attenuated PA-induced cardiomyocytes hypertrophy, inflammatory cytokines up-regulation and oxidative stress in primary cardiomyocytes and H9c2 cells. FNDC5 overexpression attenuated cardiac hypertrophy as well as cardiac inflammation and oxidative stress in HFD-fed mice. CONCLUSIONS: FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3 associated-cardiac inflammation and oxidative stress. The cardio-protective role of FNDC5 shed light on future therapeutic interventions in obesity and related cardiovascular complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1857-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-02 /pmc/articles/PMC6444535/ /pubmed/30940158 http://dx.doi.org/10.1186/s12967-019-1857-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Geng, Zhi
Fan, Wen-Yong
Zhou, Bing
Ye, Chao
Tong, Ying
Zhou, Ye-Bo
Xiong, Xiao-Qing
FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title_full FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title_fullStr FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title_full_unstemmed FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title_short FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
title_sort fndc5 attenuates obesity-induced cardiac hypertrophy by inactivating jak2/stat3-associated inflammation and oxidative stress
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444535/
https://www.ncbi.nlm.nih.gov/pubmed/30940158
http://dx.doi.org/10.1186/s12967-019-1857-8
work_keys_str_mv AT gengzhi fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT fanwenyong fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT zhoubing fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT yechao fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT tongying fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT zhouyebo fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress
AT xiongxiaoqing fndc5attenuatesobesityinducedcardiachypertrophybyinactivatingjak2stat3associatedinflammationandoxidativestress